Effectively inhibiting the level of sEH or co-inhibition of sEH with other inhibitors can have a good protective effect on renal-associated diseases, such as AKI, CKD and DN, which has been effectively verified in several researches. The gene discussed is EPHX2; the disease is acute kidney injury.